Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-18 4:23 pm Purchase | 2024-12-16 | 13D | Candel Therapeutics, Inc. CADL | Manning Paul B | 5,790,999 7.900% | 5,790,999 (New Position) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Candel Therapeutics, Inc. CADL | BLACKROCK INC BLK | 2,859,610 5.200% | 2,859,610 (New Position) | Filing History |
| 2025-06-30 09:55 am Purchase | 2025-06-25 | 13G | Candel Therapeutics, Inc. CADL | ACORN BIOVENTURES, L.P. | 2,580,517 5.200% | 2,580,517 (New Position) | Filing History |
| 2025-05-15 4:33 pm Sale | 2025-03-31 | 13G | Candel Therapeutics, Inc. CADL | BAKER BROS. ADVISORS LP | 2,455,108 4.990% | -526,875 (-17.67%) | Filing History |
| 2025-02-14 5:32 pm Unchanged | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | Northpond Ventures, LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:14 pm Purchase | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | BAKER BROS. ADVISORS LP | 2,981,983 6.800% | 2,981,983 (New Position) | Filing History |
| 2025-02-07 4:09 pm Unchanged | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | CVI Investments Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-07 10:18 am Purchase | 2025-01-31 | 13G | Candel Therapeutics, Inc. CADL | FMR CORP | 6,318,721 15.000% | 2,395,122 (+61.04%) | Filing History |
| 2025-02-07 10:03 am Purchase | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | FMR CORP | 3,923,599 9.300% | 3,923,599 (New Position) | Filing History |
| 2024-12-17 12:30 pm Unchanged | 2024-12-17 | 13G | Candel Therapeutics, Inc. CADL | CVI Investments Inc. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-09 09:59 am Unchanged | 2023-02-09 | 13G | Candel Therapeutics, Inc. CADL | FMR CORP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:40 pm Unchanged | 2022-02-14 | 13G | Candel Therapeutics, Inc. CADL | Northpond Ventures, LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:38 pm Unchanged | 2022-02-14 | 13D | Candel Therapeutics, Inc. CADL | Manning Paul B | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-09 09:11 am Unchanged | 2022-02-09 | 13G | Candel Therapeutics, Inc. CADL | FMR CORP | 0 0.000% | 0 (Unchanged) | Filing |